Home / Health / Beyond the Lump: Unveiling Breast Cancer's Many Faces
Beyond the Lump: Unveiling Breast Cancer's Many Faces
13 Feb
Summary
- Breast cancer encompasses diverse subtypes, not just one disease.
- Subtype classification significantly impacts treatment and prognosis.
- Rare breast cancer forms require specialized multidisciplinary care.
Breast cancer is a diverse family of diseases, not a single entity. While invasive carcinoma of no special type (NST) is the most common, other subtypes like invasive lobular carcinoma (ILC) present differently and require tailored approaches. Pathological diagnosis, including receptor status, is critical in determining the most effective treatment, moving beyond a one-size-fits-all approach.
Some breast cancer subtypes, such as tubular and mucinous carcinomas, are biologically gentle and respond well to less intensive treatments like surgery and hormone therapy. Conversely, aggressive subtypes like invasive micropapillary and metaplastic carcinomas necessitate careful management due to their higher risk of spread. Accurate pathology and multidisciplinary team planning are paramount for optimal outcomes.
Phyllodes tumours and male breast cancer represent other variations that require distinct recognition and care. Phyllodes tumours, arising from different breast tissue, can grow rapidly. Male breast cancer, though rare, shares warning signs with female breast cancer and demands prompt medical attention. Timely evaluation of any persistent breast changes, regardless of subtype, is essential.
